In setback to banks, NCLT orders Sterling Biotech liquidation1 min read . Updated: 10 May 2019, 09:02 PM IST
- NCLT bench of judges said as they have not received a resolution plan within the time, leaving them with no other option but to order liquidation
- The order stated that the amount deposited by the absconding promoters for the one-time settlement shall not be released to the applicant
MUMBAI : In a major setback to banks, the NCLT Friday sent Sterling Biotech for liquidation, rejecting the lenders' led by Andhra Bank, plea to withdraw the insolvency process and allow a one-time settlement with the absconding promoters, the Sandesara brothers.
A National Company Law Tribunal (NCLT) bench of judges VP Singh and Ravikumar Duraisamy said as they have not received a resolution plan within the time, leaving them with no other option but to order liquidation.
Further, the order stated that the amount deposited by the absconding promoters for the one-time settlement shall not be released to the applicant.
The lenders have already got a little over 5% of the default amount of ₹179.67 crore from the outstanding amount on the day of default.
The lenders, led by Andhra Bank, had sought the tribunal's approval after accepting the one-time settlement from the Sandesara brothers, the fugitive promoters of Sterling Biotech.
The banks had approved a one-time settlement offer from the Sandesaras of around ₹3,945 crore out of the ₹7,500 crore they owe to the lenders.
Apart from defaults, the promoters are also accused of fraud and are being investigated by the CBI, the ED and the Serious Frauds Investigation Office for money laundering. They have reportedly attached assets worth ₹4,700 crore.
The Sterling group owes over ₹15,600 crore to its financial and operational creditors. While the flagship Sterling Biotech owes over ₹7,500 crore, sister concern Sterling SEZ owes over ₹8,100 crore.
This story has been published from a wire agency feed without modifications to the text.